No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Itaconix said on Friday that first-half revenue rose to a record $8.3m, up 72% from a year earlier, prompting the plant-based specialty polymers group to raise its full-year sales outlook above market expectations.
Growth was driven across all major product segments, with strong demand from existing customers and new detergent customers in Europe and North America, while the gross profit margin is expected to remain in line with 2025 at 36%.
The AIM-traded company now expects FY26 revenue of at least $14.8m, ahead of current analyst forecasts of $13.3m, while continuing to target a small positive EBITDA despite ongoing investment in product development and headcount.
Itaconix said it was also progressing longer-term growth opportunities for its BIO*Asterix specialty monomers and binders in paints and its BioVail plant nutrition ingredient for agriculture.
At 0849 BST, shares in Itaconix were up 18.72% at 139.5p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.